Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma

Journal of Cutaneous Pathology

Volumn 37, Issue 2, 2010, Pages 231-238

  Ivan, Doina ^a   Prieto, Victor G ^a   Esmaeli, Bita ^a   Wistuba, Ignacio I ^a   Tang, Ximing ^a   Lazar, Alexander J F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 74049134387     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2009.01316.x     Document Type: Article

References (36)

1. Nelson BR, Hamlet KR, Gillard BAM, et al. Sebaceous carcinoma. J Am Acad Dermatol 1995 33 : 1.
2. Graham RM, McKee H, McGibbon D. Sebaceous carcinoma Clin Exp Dermatol 1984 9 : 466.
3. Pricolo VE, Rodil JV, Vezeridis MP. Extraorbital sebaceous carcinoma J Am Acad Dermatol 1995 33 : 1.
4. Wick MR, Goellner JR, Wolfe JT, Su WPD. Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas. Cancer 1985 56 : 1163.
5. Harvey JT, Anderson RL. The management of meibomian gland carcinoma Ophthalmic Surg 1982 13 : 56.
6. Rao NA, McLean IW, Zimmerman LE. Sebaceous carcinoma of the eyelid and caruncle: correlation of the clinical pathologic features with prognosis. In Jakobiec FA, ed. Ocular and adnexal tumors Birmingham, AL : Aesculapius, 1978 461.
7. Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexal Surv Opthalmol 1989 33 : 477.
8. Font RL. Sebaceous gland tumors. In Spencer WH, ed. Ophtalmic Pathology Vol. 4, An atlas and textbook., 4th ed. Philadelphia : WB Saunders : 1996 2278.
9. Singh RS, Grayson W, Redston M, et al. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia Am J Surg Pathol 2008 32 : 936.
10. Lazar AJ, Lyle S, Calonje E. Sebaceous neoplasia and Torre-Muir syndrome Curr Diagn Pathol 2007 13 : 301.
11. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995 33 : 90.
12. Chhibber V, Dresser K, Mahalingam M. MSH-6: extending the reliability of immunohistochemistry as a screening tool in Muir-Torre syndrome Mod Pathol 2008 21 : 159.
13. Wolfe JT 3rd., Yeatts RP, Wick MR, Campbell RJ, Waller RR. Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol 1984 8 : 597.
14. Doxanas MT, Green WR. Sebaceous gland carcinoma: review of 40 cases Arch Ophthalmol 1984 102 : 245.
15. Shields JA, Demirci H, Marr BP, Eagle RC Jr., Shields CL. Sebaceous carcinoma of the eyelids: personal experience with 60 cases Ophthalmology 2004 111 : 2151.
16. Rao NA, Hidayat AA, McLean IW, Zimmerman LE. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data Hum Pathol 1982 13 : 113.
17. Hernandez-Perez E, Banos E. Sebaceous carcinoma: report of two cases with metastasis Dermatologica 1978 156 : 184.
18. Rulon DB, Helwig EB. Cutaneous sebaceous neoplasms. Cancer 1974 33 : 82.
19. Moreno C, Jacyk WK, Judd MJ, et al. Highly aggressive extraocular sebaceous carcinoma Am J Dermatopathol 2001 23 : 450.
20. Carpenter G, Cohen S. Epidermal growth factor Annu Rev Biochem 1979 48 : 193.
21. Liu Z, Carvajal M, Carothers-Carraway CA, et al. Expression of the receptor tyrosine kinases, epidermal growth factor receptor ErbB2, Erb B3 in human ocular surface epithelia Cornea 2001 20 : 81.
22. Shatos MA, Rios JD, Horikawa Y, et al. Isolation and characterization of cultured humal conjunctival gobletcells Invest Ophtalmol vis Sci 2004 44 : 2477.
23. Nanney LB, Magid M, Stoscheck MC, et al. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages J Invest Dermatology 1984 83 : 385.
24. Matias JR, Orentreich N. Stimulation of hamster sebaceous glands by epidermal growth factor J Invest Dermatol 1983 80 : 516.
25. Kodama T, Hayasaka S, Setogawa T. Immunohistochemical localization of epidermal growth factor receptor and epithelial antigen in tumors of the human conjunctiva, eyelid, lacrimal gland and orbit Graefes Arch Clin Exp Ophtalmol 1995 233.
26. Takano T, Ohe Y, Sakamoto H, et al. Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small cell lung cancer J Clin Oncol 2005 23 : 6829.
27. Shigematsu H, Lin L, Takahashi T, et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers J Natl Cancer Inst 2005 97 : 339.
28. Tang X, Shigematsu H, Bekele BN, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients Cancer Res 2005 65 : 7568.
29. Tang X, Varella-Garcia M, Xavier A, et al. Epidermal growth factor receptor abnormalities in the pathogenesis and progression of lung adenocarcinoma Cancer Prevention Research 2008 1 : 192.
30. Cameron SEH, Cameron JD, Manivel JC, et al. Sebaceous Carcinomas of the Eyelid Are Frequently EGFR Positive and HER-2/neu Negative. Poster 1391 accepted at the USCAP Annual Meeting 2007.
31. Putti TC, To KF, Hsu HC, et al. Expression of epidermal growth factor receptor in head and neck cancers correlates with clinical progression: a multicenter immunohistochemical study in the Asia-Pacific region Histopathology 2002 41 : 144.
32. Shepler TR, Prieto VG, Diba R, Neuhaus RW, Shore JW, Esmaeli B. Expression of the epidermal growth factor receptor in conjunctival squamous cell carcinoma Ophthal Plast Reconstr Surg 2006 22 : 113.
33. Kim YT, Park SW, Kim JW. Correlation between expression of EGFR and the prognosis of patients with cervical carcinoma Gynecol Oncol 2002 87 : 84.
34. Liberman TA, Nusbaum HR, Razon N, et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary hunman brain tumors of glial origin Cancer Res 2000 60 : 1383.
35. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 2004 101 : 13306.
36. Shalan N, Hoff PM. The Role of EGFR Inhibition in Colorectal Cancer. In Markman M, Saltz LB eds. Current Clinical Oncology: colorectal cancer Humana Press, 2007 99.